AstraZeneca vaccine results to be out around Christmas, SK Bioscience already manufacturing
IndustryNov 20, 2020
AstraZeneca and Oxford University’s co-developed COVID-19 vaccine AZD1222 has shown immune response in older adults enrolled in a phase 2 clinical trial of the drug. Phase 3 clinical trial results are anticipated to be released around Christmas, the researchers said Friday. SK Bioscience, the Korean vaccine producer who in July signed with AstraZeneca to manufacture its COVID-19 vaccine, confirmed with The Korea Herald on Friday that manufacturing has been going without a glitch. AZD